title: Critical Review: Building on the HIV Cascade: A Complementary "HIV States and Transitions" Framework for Describing HIV Diagnosis, Care, and Treatment at the Population Level.
abstract: The HIV cascade--often referred to as "the HIV continuum"--provides a valuable framework for population-level representations of engagement with the HIV healthcare system. The importance and appeal of this framework are evidenced by a large body of scientific literature, as well as by the adoption of cascade-related indicators by medical and public health organizations worldwide. Despite its centrality in the fields of HIV treatment and prevention, however, the traditional cascade provides limited description of the processes affecting the numbers it represents. Representations that describe these processes and capture the dynamic nature of HIV-infected persons' pathways through the healthcare system are essential for monitoring and predicting intervention effects and epidemic trends. We propose here a complementary schema--termed the "HIV States and Transitions" framework--designed to maintain key strengths of the traditional cascade while addressing key limitations and more fully describing the dynamic aspects of HIV testing, care, and treatment at the population level.
authors.affiliation: *Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC; and †Department of Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Powers
authors.forename: William C
authors.initials: WC
authors.lastname: Miller
mesh_terms: D019090:Case Management; D019033:Delivery of Health Care, Integrated; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D006297:Health Services Accessibility; D006801:Humans; D016032:Randomized Controlled Trials as Topic
references.citation: PLoS One. 2011;6(7):e21797
references.pmid: 21818265
references.citation: Clin Infect Dis. 2011 Mar 15;52(6):793-800
references.pmid: 21367734
references.citation: AIDS. 2012 Jan 2;26(1):77-86
references.pmid: 22008656
references.citation: MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1618-23
references.pmid: 22129997
references.citation: AIDS. 2012 Sep 10;26(14):1735-8
references.pmid: 22614888
references.citation: J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S228-32
references.pmid: 23764640
references.citation: PLoS One. 2013;8(8):e72257
references.pmid: 23967292
references.citation: Public Health Rep. 2013 Sep-Oct;128(5):354-9
references.pmid: 23997280
references.citation: Clin Infect Dis. 2013 Oct;57(8):1164-71
references.pmid: 23797289
references.citation: J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):622-30
references.pmid: 23614992
references.citation: Sex Transm Dis. 2014 Jan;41(1):35-40
references.pmid: 24326579
references.citation: Sex Transm Dis. 2014 Jan;41(1):41-2
references.pmid: 24326580
references.citation: MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):85-9
references.pmid: 24500286
references.citation: Int J Epidemiol. 2007 Apr;36(2):294-301
references.pmid: 17213214
references.citation: J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):446-53
references.pmid: 16010168
references.citation: J Int AIDS Soc. 2014;17:18908
references.pmid: 24780511
references.citation: Clin Infect Dis. 2008 Aug 15;47(4):577-84
references.pmid: 18624629
references.citation: Int J Epidemiol. 2008 Oct;37(5):948-55
references.pmid: 18263650
references.citation: Health Aff (Millwood). 2009 Nov-Dec;28(6):1677-87
references.pmid: 19887408
references.citation: AIDS Patient Care STDS. 2010 Oct;24(10):607-13
references.pmid: 20858055
references.citation: Clin Infect Dis. 2011 Jan 15;52 Suppl 2:S238-46
references.pmid: 21342913
references.citation: N Engl J Med. 2011 Aug 11;365(6):493-505
references.pmid: 21767103